Technical Data
P1001-37R
p70 S6 Kinase, phosphorylated, Thr398 (Drosophila) (p70 S6K)
Description:
p70 S6 kinase is a mitogen activated Ser/Thr protein kinase that is required for cell growth and G1 cell cycle progression. p70 S6 kinase phosphorylates the S6 protein of the 40S ribosomal subunit and is involved in translational control of 5' oligopyrimidine tract mRNAs. A second isoform, p85 S6 kinase, is derived from the same gene and is identical to p70 S6 kinase except for 23 extra residues at the amino-terminus, which encode a nuclear localizing signal. Both isoforms lie on a mitogen activated signaling pathway downstream of phosphoinositide-3 kinase (PI-3K) and the target of rapamycin, FRAP/mTOR, a pathway distinct from the Ras/MAP kinase cascade. The activity of p70 S6 kinase is controlled by multiple phosphorylation events located within the catalytic, linker and pseudosubstrate domains. Phosphorylation of Thr229 in the catalytic domain and Thr389 in the linker domain are most critical for kinase function. Phosphorylation of Thr389, however, most closely correlates with p70 kinase activity in vivo. Prior phosphorylation of Thr389 is required for the action of phosphoinositide 3-dependent protein kinase 1 (PDK1) on Thr229. Phosphorylation of this site is stimulated by growth factors such as insulin, EGF and FGF, as well as by serum and some G-protein-coupled receptor ligands, and is blocked by wortmannin, LY294002 (PI-3K inhibitor) and rapamycin (FRAP/mTOR inhibitor). Ser411, Thr421 and Ser424 lie within a Ser-Pro-rich region located in the pseudosubstrate region. Phosphorylation at these sites is thought to activate p70 S6 kinase via relief of pseudosubstrate suppression. Another LY294002 and rapamycin sensitive phosphorylation site, Ser371, is an in vitro substrate for mTOR and correlates well with the activity of a partially rapamycin resistant mutant p70 S6 kinase.

Applications:
Suitable for use in Western Blot. Other applications not tested.

Recommended Dilutions:
Western Blot:1:1000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
100ul-20CBlue IceDrosophilaRabbit
Concentration:
Not Determined
Immunogen:
Synthetic phosphopeptide corresponding to residues surrounding Thr398 of Drosophila p70 S6 kinase, conjugated to KLH.
Purity:
Purified by Protein A and peptide affinity chromatography.
Form
Supplied as a liquid in 10mM sodium HEPES, pH 7.5, 150mM sodium chloride, 0.1mg/ml BSA, 50% glycerol.
Specificity:
Recognizs endogenous levels of Drosophila p70 S6 kinase only when phosphorylated at threonine 398. Also recognize human p70 S6 Kinase when phosphorylated at threonine 389.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Pullen, N. and Thomas, G. (1997) FEBS Lett. 410, 7882. 2. Dunfer, A. et al. (1999) Exp. Cell Res. 253, 100109. 3. Weng, Q.P. et al. (1998) J. Biol. Chem. 273, 1662116629. 4. Pullen, N. et al. (1998) Science 279, 707710. 5. Alessi, D. et al. (1998) Curr. Biol. 8, 6981. 6. Polakiewicz, R.D. et al. (1998) J. Biol. Chem. 273, 2353423541. 7. Finger, D.C. et al. (2002) Genes Dev. 16, 14721487. 8. Saitoh, M. et al. (2002) J. Biol. Chem. 277, 2010420112. 9. Montagne, J. et al. (1999) Science 285, 21262129. 10. Radimerski, T. et al. (2002) Nat. Cell Biol. 4, 251255. 11. Lizcano, J.M. et al. (2003) Biochem. J. 374, 297306. 12. Miron, M. et al. (2003) Mol. Cell. Biol. 23, 91179126.